Global
中文 English

Investor Relations

Investor Relations

Corporate Governance

Senior Executives

Porton’s senior executives bring decades of pharmaceutical industry and CDMO experience. Reporting to Chairman and CEO Nianfeng (Oliver) Ju, they lead key functional groups such as R&D, Manufacturing Operations, Quality Assurance, Finance, and Corporate Development.

Senior Executives

Mr.Nianfeng JUChairman and CEO

Mr. Nianfeng Ju is one of the co-founders of and De-Facto Controllers of Porton.

Mr.Rong TAOBoard Secretary

Mr. Rong Tao is one of the co-founders and De-Facto Controllers of Porton.

Ms.Kerry YUSenior Vice President

Formerly worked as a pharmacist in Chongqing Institute for Drug Control and had years of experience in quality system in GSK. Before joining Porton, she was the strategy development director and deputy plant manager of Chongqing Carelife Pharmaceutical Co. Ltd.

Mr.Yaohui JIVice President

He started his professional career in Roche Carolina Inc. and then joined Novartis Suzhou Pharma Tech and STA. He now acts as the VP of R&D, overseeing the R&D operations of Shanghai/Chongqing R&D Centers, ARD Centers and Technology Platform.

Mr. Min SUN Vice President and CFO

He graduated from China-Europe International Business School and obtained his master degree of EMBA. Min got the certificate of Certified Public Accountant of China. He once served one of the International TOP 4 Accounting firms,insurance groups and leading start-ups in the internet medical industry. He is now in charge of strategic investment and financial management in Porton.

Legal Notices About Porton Investor Relations

Fangzheng Avenue, Shuitu, Beibei District, Chongqing, China.

Copyright © 2020 Porton Group. DIGITAL BY VTHINK

渝ICP备11005917号-1